Personalization of Radiotherapy Dose in HPV Positive Oropharynx Cancer Using GARD.

Saved in:
Bibliographic Details
Title: Personalization of Radiotherapy Dose in HPV Positive Oropharynx Cancer Using GARD.
Authors: Ho E; Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.; School of Medicine, Case Western Reserve University, Cleveland, OH., De Cecco L; UO Molecular Mechanisms, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Eschrich SA; Department of Biostatistics and Biomedical Informatics, Moffitt Cancer Center, Tampa, FL., Cavalieri S; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Sedor G; Radiation Oncology Department, NYPH/Columbia University Vagelos College of Physicians and Surgeons, New York, NY., Hoebers F; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., Brakenhoff RH; Amsterdam UMC, Vrije Universiteit Amsterdam, Otolaryngology/Head and Neck Surgery, Cancer Center Amsterdam, the Netherlands., Scheckenbach K; Department of Otolaryngology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Poli T; Unit of Maxillofacial Surgery, Department of Medicine and Surgery, University of Parma-University Hospital of Parma, Parma, Italy., Yang K; Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA., Scarborough JA; Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.; School of Medicine, Case Western Reserve University, Cleveland, OH., Nellore S; Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.; School of Medicine, Case Western Reserve University, Cleveland, OH., Campbell S; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH., Woody N; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH., Chan T; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH.; Center for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH., Miller J; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH.; Center for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH., Silver N; Center for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH., Koyfman S; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH., Bates J; Department of Radiation Oncology, Emory University, Atlanta, GA., Caudell JJ; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL., Kattan MW; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland OH., Licitra L; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Torres-Roca JF; Department of Biostatistics and Biomedical Informatics, Moffitt Cancer Center, Tampa, FL.; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL., Scott JG; Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.; School of Medicine, Case Western Reserve University, Cleveland, OH.; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH.; Departments of Physics and Biology, Case Western Reserve University, Cleveland, OH.
Source: MedRxiv : the preprint server for health sciences [medRxiv] 2025 May 02. Date of Electronic Publication: 2025 May 02.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
DOI:10.1101/2023.09.14.23295538